Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
AOR vs XLV: how they differ
AOR and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
iShares Core 60/40 Balanced Allocation ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, AOR and XLV hold 0% of their money in the same securities at the same weight.
| Only in AOR | Only in XLV |
|---|---|
| iShares Core S&P 500 ETF 35.07% | Eli Lilly & Co 16.56% |
| iShares Core Universal USD Bond ETF 32.09% | Johnson & Johnson 10.67% |
| iShares Core MSCI International Develope 17.02% | AbbVie Inc 7.76% |
| iShares Core MSCI Emerging Markets ETF 7.29% | UnitedHealth Group Inc 6.59% |
| iShares Core International Aggregate Bon 5.57% | Merck & Co Inc 5.54% |
| iShares Core S&P Mid-Cap ETF 1.99% | Amgen Inc 3.41% |
| iShares Core S&P Small-Cap ETF 0.96% | Thermo Fisher Scientific Inc 3.25% |
| Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| AOR iShares Core 60/40 Balanced Allocation ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | Core 60/40 Balanced Allocation | Health care |
| Total return, 1 year | +11.3% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −6.2 pts | +2.9 pts |
| Expense ratio | 0.15% | 0.08% |
| Already in the S&P 500 | 0.0% | 100.0% |
| Holdings | 7 | 59 |
AOR in plain words
AOR is an index equity fund tracking the Core 60/40 Balanced Allocation. Over the year to Sep 11, 2026 it returned +11.3% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.15% a year. By its holdings filed for Apr 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 7 positions, with the top ten at 100.0%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, AOR or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, AOR returned +11.3% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, AOR or XLV?
- AOR charges 0.15% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do AOR and XLV overlap with the S&P 500?
- By their latest filed holdings, 0% of AOR and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, AOR against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/AOR-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources